-
Mashup Score: 0
Triplet therapy of belantamab mafodotin, bortezomib, dexamethasone beneficial for relapsing or refractory multiple myeloma.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0Tocilizumab in Multiple Myeloma Patients - 15 day(s) ago
Tyler Sandahl, MD, Clinical Pharmacist at the Mayo Clinic, discusses the use of Tocilizumab in multiple myeloma patients.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0Tocilizumab in Multiple Myeloma Patients - 1 month(s) ago
Tyler Sandahl, MD, Clinical Pharmacist at the Mayo Clinic, discusses the use of Tocilizumab in multiple myeloma patients.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0
Triplet therapy of belantamab mafodotin, bortezomib, dexamethasone beneficial for relapsing or refractory multiple myeloma.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0
Triplet therapy of belantamab mafodotin, bortezomib, dexamethasone beneficial for relapsing or refractory multiple myeloma.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0Tocilizumab in Multiple Myeloma Patients - 2 month(s) ago
Tyler Sandahl, MD, Clinical Pharmacist at the Mayo Clinic, discusses the use of Tocilizumab in multiple myeloma patients.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
Triplet therapy of belantamab mafodotin, bortezomib, dexamethasone beneficial for relapsing or refractory multiple myeloma #CheckRare #RareDisease #MultipleMyeloma https://t.co/brnIpmh20f